Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Hidalgo

Showing results (11-20 of 384) with videos related to

Pageof 39
Sort By:
Breast Cancer Research : BCR|August 21, 2004
New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonistsHetty Carraway, Manuel Hidalgo
Methods in Molecular Biology (Clifton, N.J.)|April 9, 2025
Sperm Vitrification in Horse and DonkeyManuel Hidalgo, Isabel Ortiz
The New England Journal of Medicine|November 20, 2009
The hedgehog pathway and pancreatic cancerManuel Hidalgo, Anirban Maitra
Seminars in Oncology|July 4, 2003
Pharmacokinetics and pharmacodynamics: maximizing the clinical potential of Erlotinib (Tarceva)Manuel Hidalgo, Duane Bloedow
Journal of the National Cancer Institute|June 19, 2003
Developing inhibitors of the epidermal growth factor receptor for cancer treatmentViktor Grünwald, Manuel Hidalgo
Biochimica Et Biophysica Acta|October 19, 2006
Pharmacogenomics of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsAntonio Jimeno, Manuel Hidalgo
Critical Reviews in Oncology/Hematology|February 19, 2005
Blockade of epidermal growth factor receptor (EGFR) activityAntonio Jimeno, Manuel Hidalgo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2019
Reply to I. Pecora et alTeresa Macarulla, Manuel Hidalgo
Genome Medicine|July 31, 2012
Getting personalized cancer genome analysis into the clinic: the challenges in bioinformaticsAlfonso Valencia, Manuel Hidalgo
Current Problems in Cancer|June 27, 2002
The epidermal growth factor receptor: a new target for anticancer therapyViktor Grünwald, Manuel Hidalgo
Pageof 39

Showing results (11-20 of 384) with videos related to

Sort By:
Pageof 39
Breast Cancer Research : BCR|August 21, 2004
New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonistsHetty Carraway, Manuel Hidalgo
Methods in Molecular Biology (Clifton, N.J.)|April 9, 2025
Sperm Vitrification in Horse and DonkeyManuel Hidalgo, Isabel Ortiz
The New England Journal of Medicine|November 20, 2009
The hedgehog pathway and pancreatic cancerManuel Hidalgo, Anirban Maitra
Seminars in Oncology|July 4, 2003
Pharmacokinetics and pharmacodynamics: maximizing the clinical potential of Erlotinib (Tarceva)Manuel Hidalgo, Duane Bloedow
Journal of the National Cancer Institute|June 19, 2003
Developing inhibitors of the epidermal growth factor receptor for cancer treatmentViktor Grünwald, Manuel Hidalgo
Biochimica Et Biophysica Acta|October 19, 2006
Pharmacogenomics of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsAntonio Jimeno, Manuel Hidalgo
Critical Reviews in Oncology/Hematology|February 19, 2005
Blockade of epidermal growth factor receptor (EGFR) activityAntonio Jimeno, Manuel Hidalgo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2019
Reply to I. Pecora et alTeresa Macarulla, Manuel Hidalgo
Genome Medicine|July 31, 2012
Getting personalized cancer genome analysis into the clinic: the challenges in bioinformaticsAlfonso Valencia, Manuel Hidalgo
Current Problems in Cancer|June 27, 2002
The epidermal growth factor receptor: a new target for anticancer therapyViktor Grünwald, Manuel Hidalgo
Pageof 39